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Higher induction of apoptosis
occurs in high linear energy
transfer (LET)–irradiated
cells than in low LET–irradi-
ated cells. Similar induction of
the profibrotic plasminogen
activator inhibitor 1 gene
occurs with high and low LET
radiation. Phosphorylation of
p53 at serine 315 is involved in
plasminogen activator inhib-
itor 1 expression and is similar
after high and low LET radia-
tion. Phosphorylation of p53
at serine 37 is involved in
apoptosis and is much higher
after highLETirradiation than
in low LET–irradiated cells.
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Open access undPurpose: Radiotherapy using high linear energy transfer (LET) radiation is aimed at effi-
ciently killing tumor cells while minimizing dose (biological effective) to normal tissues
to prevent toxicity. It is well established that high LET radiation results in lower cell
survival per absorbed dose than low LET radiation. However, whether various mechanisms
involved in the development of normal tissue damage may be regulated differentially is
not known. Therefore the aim of this study was to investigate whether two actions related
to normal tissue toxicity, p53-induced apoptosis and expression of the profibrotic gene
PAI-1 (plasminogen activator inhibitor 1), are differentially induced by high and low LET
radiation.
Methods and Materials: Cells were irradiated with high LET carbon ions or low LET photons.
Cell survival assays were performed, profibrotic PAI-1 expression was monitored by quantitative
polymerase chain reaction, and apoptosis was assayed by annexin V staining. Activation of p53
by phosphorylation at serine 315 and serine 37 was monitored by Western blotting. Transfec-
tions of plasmids expressing p53 mutated at serines 315 and 37 were used to test the requirement
of these residues for apoptosis and expression of PAI-1.
Results: As expected, cell survival was lower and induction of apoptosis was higher in high -LET
irradiated cells. Interestingly, induction of the profibrotic PAI-1 gene was similar with high and
low LET radiation. In agreement with this finding, phosphorylation of p53 at serine 315 involved
in PAI-1 expression was similar with high and low LET radiation, whereas phosphorylation of
p53 at serine 37, involved in apoptosis induction, was much higher after high LET irradiation.
Conclusions: Our results indicate that diverse mechanisms involved in the development of
normal tissue damage may be differentially affected by high and low LET radiation. This may
have consequences for the development and manifestation of normal tissue damage.
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The quality of life of cancer patients treated with radiotherapy
may be severely hampered by radiation-induced side effects,
which may even limit the treatment dose and thereby reduce
tumor control probability (1e4). Because the risk of normal tissue
complications depends on irradiated normal tissue volume and
dose, developments in radiotherapy such as high linear energy
transfer (LET) particle therapy are aimed at reducing the amount
of normal tissue that is co-irradiated (5, 6). However, high LET
particle therapy is more complex and expensive than conventional
radiotherapy. Therefore treatment focuses on localized tumors in
proximity to critical organs or tumors resistant to conventional
treatments. Clinically, the use of such treatment is therefore
currently limited to cancers such as uveal melanoma, pediatric
tumors, skull base tumors, and head-and-neck tumors (6, 7). Given
the limited number of applications so far, the risk of induction of
late normal tissue damage and second malignancies with particle
therapy cannot yet be predicted accurately (6e8).
In particle irradiations, both protons and heavy ions share an
advantage in physical dose distribution, allowing a more conformal
dose delivery to the tumor than irradiation with the conventionally
used photons (6, 7). The density of ionization events, or LET, is
higher for radiation with heavy ions than for photons and protons,
giving heavy ions an additional potential biologic advantage
because cell death increases with LET (5, 6). However, normal
tissue effects are not exclusively caused by cell death but are caused
by a combination of cell death and other processes such as cell
differentiation, epithelial to mesenchymal transition, proliferation
of specific cells, extracellular matrix deposition, and many other
reactions (1e3, 9, 10). Large variations in the relative biologic
effectiveness (RBE) of particles have been measured in different
studies (11, 12). The observation that differences in RBE are
endpoint specific and tissue specific (11, 12) suggests that high
LET radiation may not only differ from low LET radiation in
severity of cell death induction but also in the type of mechanisms it
activates. Different organs respond to radiation by activating
specific mechanisms, which results in tissue-specific manifesta-
tions of normal tissue toxicity (3, 13). Some organs, such as the
lungs, can even show two distinct types of normal tissue toxicity
after radiationdpneumonitis and fibrosisdthat show different
manifestations depending on irradiated dose and volume (4, 14).
Fibrosis is induced by activation of cell signaling and cytokines,
which regulate proteins inducing the tissue remodeling seen in
fibrotic tissue (1e3, 9, 15, 16). One such protein, plasminogen
activator inhibitor 1 (PAI-1), is the main inhibitor of the fibrinolytic
system (10, 15). PAI-1 regulates the degradation of extracellular
matrix components (10, 15). An increase of PAI-1 expression
therefore disturbs the extracellular matrix balance, which results in
fibrotic reactions as seen in medical conditions including radiation-
induced fibrosis (10, 15). Because PAI-1 is regulated cooperatively
by radiation [in a p53-dependent fashion (17)] and hypoxia (18) or
transforming growth factor b (17, 19, 20), changes in radiation dose
potentially lead to a particularly large deviation in PAI-1 expression
in hypoxic or transforming growth factor berich areas. During
radiotherapy, DNA is the primary target and specific DNA damageis required for cell killing (21, 22). It has been shown that the
physical differences between high LET radiation and low LET
radiation have a distinct impact on the induction of DNA damage,
causing unambiguous differences in the properties of the damaged
DNA (21, 23). Late radiation effects eventually leading to organ
dysfunction involve signals such as those induced by the p53
pathway in response to DNA damage (9, 24). In response to gen-
otoxic stress, the p53 protein is activated by phosphorylation at
numerous sites, depending on the severity and type of DNA damage
and on cell type (25, 26). In this way p53 phosphorylation patterns
are generated that result in specific activation of the p53 protein that
can consequently activate specific (albeit not exclusive) processes
such as apoptotic cell death and induction of genes involved in
tissue remodeling such as PAI-1 (10, 17, 27e29). However, those
signals vary in type and severity according to the characteristics of
the DNA damage (e.g., the complexity of the DNA damage formed)
(25, 26, 28). This introduces different responses to high and low
LET radiation (7), potentially resulting in a different development
and manifestation of normal tissue complications.
The aim of this study was therefore to investigate whether
a difference in the induction of two completely different processes
related to normal tissue damage, p53-induced apoptosis and p53-
regulated expression of the profibrotic PAI-1 gene (2, 3, 9, 17, 20, 29),
can be observed after high and low LET irradiation. We show that
high and lowLETradiation differentially induces these two actions in
an unparalleledway. This finding indicates that the profile of biologic
mechanisms contributing to normal tissue damage induced by high
and lowLETradiationmay differ, thus potentially leading to different
manifestations and development of normal tissue damage.Methods and Materials
Cell culture and irradiation
Human alveolar basal epithelial cells (A549) and human embryonic
kidney cells (HEK293) were maintained in DMEM Dulbecco’s
Modified Eagle Medium (DMEM) (complete medium) supple-
mented with 10% fetal bovine serum and irradiated as described
previously (30) with (high LET) 90 mega-electronvolt per nucleon
(MeV/u) carbon ions in a 1.3-mm-long spread-out Bragg peak with
a diameter of 30 mm, allowing accurate irradiation of the cells. At
the position of the sample, the track-averaged LET was 132  10
keV/mm whereas the dose-averaged LET was 189  15 keV/mm.
Experiments were performed with a dose rate between 3 and 5 Gy/
min (30). If this resulted in irradiation times shorter than 10 seconds,
the dose rate was reduced by a factor of 10 by reducing the beam
current injected into the cyclotron (30). We irradiated (low LET)
photon-irradiated samples with a 137Cs source (IBL637 g-radiation
machine, CIS Biointernational, Gif-Sur-Yvette, France) with a dose
rate of 0.636 Gy/min. Survival assays were performed as described
previously (30). Apoptosis was monitored with a microscope or
a fluorescence-activated cell sorter after the cells were stained by
use of the Annexin VeCy3 Apoptosis Kit (BioVision, Mountain
View, CA) according to the manufacturer’s protocol.
Fig. 1. Cell survival is lower for high linear energy transfer
(LET) radiation than for low LET radiation, whereas plasminogen
activator inhibitor 1 (PAI-1) expression is similar. (A) Colony-
forming (survival) assay of A549 cells, irradiated with indicated
doses of photons (cesium source [blue]) or with carbon ions (red).
Cell cultures and treatments were performed identically and
simultaneously in each experiment. (B) Quantitative polymerase
chain reaction (qPCR) quantification of PAI-1 messenger RNA
(mRNA) levels in A549 cells 24 h after irradiation with high (red)
and low (blue) LET radiation. (C) Colony-forming (survival)
assay of HEK293 cells, irradiated with indicated doses of photons
(cesium source [blue]) or with carbon ions (red). Each data point
is the mean of at least three individual experiments with similar
results. Cell cultures and treatments were performed identically
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pcDNAep53 (wild type) has been described previously (20).
Plasmids expressing mutated p53 were constructed by site-
directed mutagenesis with pcDNA p53 (wild type) as a template
by use of the following primers: 50-ctggcccccttgccgtcccaagcaatg
and 50-caagggggccagaacgttgttttcaggaag for p53eS37A and
50-gctccgctccccagccaaagaagaaaccac and 50-ctggggagcggagctggtg
ttgttgggc for p53eS315A. For the apoptosis assay, the pEGFP-N2
plasmid (Clontech, Mountain View, CA) was transfected in
HEK293 cells in a ratio of 1:1, in combination with pcDNA3.1þ
(Invitrogen, Paisley, Scotland) as empty vector or one of the p53
expression plasmids described earlier, with Lipofectamine (Invi-
trogen) according to the manufacturer’s protocol. The luciferase
assays were performed essentially as described previously (20);
however, we used 0.5 mg of reporter plasmid and only 5 ng of
(p53) expression plasmids per sample (this very low concentration
is sufficient to induce the PAI-1eluc plasmid but too low to induce
apoptosis in 24 h).
Western blotting and quantitative polymerase
chain reaction
Western blotting was performed as described previously (17), and
the primary antibodies were as follows: g-tubulin (Sigma-Aldrich,
St Louis, MO); (total) p53 DO-1 (Santa Cruz Biotechnology,
Santa Cruz, CA); and Phospho-p53eSer20, Phospho-p53eSer37,
Phospho-p53eSer315, and Phospho-p53eSer392 (Cell Signaling
Technology, Danvers, MA). Induction of p53 phosphorylation was
determined by quantifying bands on Western blots with the
appropriate antibody by use of ImageJ software (National Insti-
tutes of Health, Bethesda, MD) and normalizing the bands for
g-tubulin. Error bars in graphs are the standard error of the mean
of quantification of three separate Western blots, with different
protein samples. Quantitative polymerase chain reaction was
performed by use of glyceraldehyde 3-phosphate dehydrogenase
for normalization as described previously (20).and simultaneously in each experiment. (D) qPCR quantification
of PAI-1 mRNA levels in HEK293 cells 24 h after irradiation with
high (red) and low (blue) LET radiation. Error bars represent
standard error of the mean. RBEZ relative biologic effectiveness.Results
Cell survival versus induction of profibrotic PAI-1
To investigate whether a difference in induction of two completely
different biologic processes related to normal tissue damage can be
observed after high and low LET irradiation, we compared cell
survival and expression of the profibrotic PAI-1 gene in A549 lung
epithelial cells (Fig. 1A) and HEK293 embryonic kidney cells
(Fig. 1C). As expected, in a clonogenic survival assay, at all levels of
cell survival, higher doses of low LET radiation were needed to
induce the same effect (Figs. 1A and 1C). The observed RBE was
about 3.4 for A549 cells and 2.3 in HEK293 cells for a level of 10%
survival (Figs. 1A and 1C, respectively). However, the increase in
expression of PAI-1 messenger RNA was virtually identical after
irradiation with high or low LET radiation (Figs. 1B and 1D). Our
results show an endpoint-specific difference in response to high and
low LET irradiation of cell survival and PAI-1 induction. HEK293
cells showed the clearest response and are most suitable for subse-
quent experiments such as transfections. Therefore, from here on,
the experiments were performed with this cell type only.High and low LET radiation induces different p53
activation
Interestingly, both apoptotic cell death (28, 29) and expression
of PAI-1 (17, 20) are regulated by p53. To find a possible expla-
nation for their differential regulation, we compared phosphory-
lation patterns of key p53 amino acid residues after high and low
LET irradiation (Fig. 2). The p53 residues serine 315 and serine 37
were induced by radiation in HEK293 (Figs. 2Ae2D), whereas
the other residues did not show a quantifiable increase in phos-
phorylation (Figs. 2A and 2B). Dose response functions for high
and low LET radiation were obtained. An increase in phosphor-
ylation of p53eSer315 was observed for both high and low LET
radiation. At the same physical dose, the observed patterns were
very similar for both types of radiation (Figs. 2Ae2D), especially
24 h after radiation (Fig. 2D). On the other hand, a large difference
between high and low LET irradiation was observed for
p53eSer37 (Figs. 2A, 2B, 2E, and 2F). For high LET radiation,
Fig. 2. p53 phosphorylation patterns after high linear energy transfer (LET), low LET, and UV-B radiation. Typical Western blot results
of phosphorylation patterns of important p53eserine residues (serine 20, 37, 315, and 392) 6 or 24 h after low LET (photon) radiation (A)
or high LET (carbon ion) radiation (B). UV-B radiation was used as internal control (6 h only) in A and B. Quantification of p53eSer315
phosphorylation 6 h (C) and 24 h (D) after low or high LET radiation, showing high similarity of p53eSer315 phosphorylation between low
and high LET radiation. Quantification of p53eSer37 phosphorylation 6 h (E) and 24 h (F) after low or high LET radiation, showing higher
p53eSer37 phosphorylation after high LET radiation. Error bars represent standard error. Asterisks, p < 0.05 by two-tailed t test.
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both 6 h (Figs. 2A and 2E) and 24 h (Figs. 2B and 2F) after
radiation. Thus the activation of p53eSer315 phosphor-
ylationdlike that of the increase in expression of PAI-1dis
similar for the same physical dose of high and low LET radiation,
whereas p53eSer37 phosphorylationdlike the induction of cell
deathdis much higher with high LET radiation.
Signals induced by high LET radiation induce
relatively more apoptosis than expression of PAI-1
Because p53 is involved in the regulation of apoptotic cell death
(26, 28, 29), we investigated whether there is a difference in
apoptosis induction by high or low LET radiation. Indeed,
consistent with the data for cell survival, the increase in the
number of apoptotic cells was significantly higher in highLETeirradiated cells after both 4 and 8 Gy (Fig. 3). This finding
indicates that apoptosis may be responsible (at least in part) for
the difference in cell survival between high and low LET
radiation.
To test whether the p53 phosphorylations monitored after
irradiation with high and low LET radiation can differentially
affect different processes, we tested whether plasmids expressing
p53 mutants for specific phosphorylation sites differentially
induce apoptosis (Figs. 4A and 4B) and PAI-1 expression
(Fig. 4C). To identify cells expressing the p53 variants in an
apoptosis assay, we co-transfected a Green Fluorescent Protein
(GFP)-expressing plasmid together with an empty vector,
a plasmid expressing wild-type p53, or a plasmid expressing p53
mutants deficient for phosphorylation at p53eserine 315
(p53eS315A) or p53eserine 37 (p53eS37A). Subsequently, the
cells were stained with Cy3-labeled annexin V to identify
apoptotic cells. After co-transfection with empty vector, green
Fig. 3. High linear energy transfer (LET) radiation induces more apoptosis than low LET radiation. HEK293 cells were mock treated or
irradiated with 4- or 8-Gy carbon ions or photons. Apoptosis was assayed by fluorescence-activated cell sorter (FACS) after staining with
annexin VeCy3 24 h after irradiation. (A) Representative FACS plots for unirradiated cells (left), cells irradiated with 8-Gy photons
(middle), and cells irradiated with 8-Gy carbon ions (right). Apoptotic cells, showing a high Cy3 signal, were gated (pink area). (B) The
increase in apoptotic cells per 50,000 hits (cells) normalized for experimental background levels (average unirradiated cells) is shown after
radiation with 4- or 8-Gy photons (low LET [blue]) or carbon ions (high LET [red]). Error bars represent standard error. Asterisk, p < 0.05
by two-tailed t test.
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apoptotic cell death as judged by the (red) annexin VeCy3
staining (Fig. 4A). However, green wild-type p53eco-transfected
cells showed a much higher rate of apoptosis 24 h after trans-
fection (Fig. 4A), showing that when p53 is overexpressed in
HEK293 cells with the used concentrations, the amount of active
p53 is sufficient to induce apoptosis and radiation is not required
to further activate p53 in order to observe apoptotic cells. Green
cells co-transfected with p53eS37A, however, showed only few
apoptotic cells 24 h after transfection. Quantification shows that
when the p53 phosphorylation site most affected by high LET
radiation is mutated, p53-induced apoptosis is reduced by more
than 75% in this experiment (Figs. 4A and 4B). In contrast,
mutation of serine 315 did not reduce the capacity of p53 to
induce apoptosis because annexin V staining was similar for wild-
type p53e and p53eS315Aetransfected cells (Figs. 4A and 4B).
However, in contrast to the effect seen for apoptosis, the p53
phosphorylation site serine 37 appeared not to be involved in PAI-
1 induction because mutation of this residue did not reduce the
capacity of p53 to induce a PAI-1 luciferase reporter construct.
Conversely, after mutation of p53eserine 315, a significantreduction in PAI-1 luciferase activity was observed (Fig. 4C). This
finding indicates that p53eserine 315 is involved in expression of
PAI-1 rather than in apoptosis.
Together, these findings show that signals that are regulated at
least partially via the same key regulator (p53 protein) of radiation-
induced biologic processes can be differentially induced by high
and low LET radiation.
Discussion
To be able to optimally exploit the benefits of irradiation of
patients with heavy ions such as carbon ions, it is essential to
adequately predict the effect of the irradiation on the treatment
outcome in comparison to the conventionally used photons. This
should take into account the difference in the response of tumors
but also of normal tissues. In cell survival experiments similar to
ours, carbon ions were found to be more effective in killing cells in
culture than photons (7, 31), which is consistent with our results.
However, we also show in two cell lines that induction of profi-
brotic PAI-1 is the same after high and low LET irradiation. In line
Fig. 4. Mutation of p53eSer37 reduces apoptotic potential of p53, whereas mutation of p53eSer315 reduces plasminogen activator
inhibitor 1 (PAI-1) activation. (A) Microscopic pictures of apoptotic cells (annexin VeCy3 [red]) after co-transfection of GFP (green) with
empty vector (control) or wild-type (wt) p53, p53eS37A, or p53eS315A plasmids. (B) Quantification of apoptosis after co-transfection of
GFP with empty vector (control) or wild-type (wt) p53, p53eS37A, or p53eS315A plasmids. (C) Induction of a PAI-1 luciferase reporter
construct by empty vector (control) or wild-type (wt) p53, p53eS37A, or p53eS315A constructs., AnnexinV-Cy3 staining: original
magnification 400 Error bars represent standard error. Asterisks, p < 0.05 by two-tailed t test.
Fig. 5. Schematic overview. High linear energy transfer (LET)
radiation has a stronger impact on cell survival and apoptosis than
low LET radiation, whereas high LET radiation and low LET
radiation similarly induce the profibrotic plasminogen activator
inhibitor 1 (PAI-1) gene. p53eserine 37 is phosphorylated more
extensively by high LET radiation, and this residue is more
important for cell death than for expression of PAI-1. On the other
hand, p53eserine 315 phosphorylation is induced similarly by
high and low LET radiation, and this residue is more involved in
PAI-1 expression than in cell death.
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radiation induces more apoptosis than low LET radiation.
p53eserine 37 was phosphorylated more extensively by high LET
radiation, and our observation that mutation of this residue reduces
the capacity of p53 to induce apoptosis in HEK293 cells suggests
its importance for apoptosis. On the other hand, p53eserine 315
phosphorylation, which was induced to a similar extent by high
and low LET radiation, evidently plays a more important role in
PAI-1 expression than in apoptosis because mutation of
p53eSer315 reduces the capacity of p53 to induce expression of
the profibrotic PAI-1 gene (a schematic overview of these results is
shown in Fig. 5).
Parenchymal cells, endothelial cells, and fibroblasts all play
a prominent but specific role in the induction of normal tissue
damage after irradiation, and signaling between these cell types, as
well as the activation of an inflammatory response in response to the
radiation-induced changes in these cells, is the trigger for induction
of normal tissue damage (1e3). A difference in the initial reaction to
radiation in any one of these cell types could already have an impact
on manifestations of normal tissue damage because the interaction
with other cell types could also change. We used lung epithelial and
embryonic kidney cells to show proof of principle that differential
activation of mechanisms involved in normal tissue damage can be
induced by high and low LET radiation.Because high and/or low LET radiation induces many
responses in addition to expression of PAI-1 and p53-induced
apoptosis, this study urges investigations of other mechanisms that
Volume 83  Number 4  2012 LET dependence of normal tissue damage signals 1297might be induced differentially, for example, p53-independent
apoptosis (32, 33) as induced by high LET radiation through
caspases 3 and 9 and Chk2 (34). These and other processes, in
concert with p53-dependent processes such as those described in
this study, could illuminate differential normal tissue responses to
and between high and low LET radiation.
Our study implies that the comprehensive effect of high LET
radiation on normal tissue cannot be determined by the measure-
ment of one single mechanism. These findings may have impli-
cations for the development of new high LET radiation treatments.
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